These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34801697)

  • 1. Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients.
    Malapelle U; Pilotto S; Reale ML; Passiglia F; Pisapia P; Pepe F; Belluomini L; Galetta D; Cortinovis D; Tiseo M; Passaro A; Seminati D; Pagni F; Parra HS; Migliorino MR; Rocco D; Troncone G; Novello S
    Crit Rev Oncol Hematol; 2022 Jan; 169():103536. PubMed ID: 34801697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Treatments for Advanced Non-Small-Cell Lung Cancer With Exon 20 Insertion Epidermal Growth Factor Receptor Mutations.
    Wu JY; Yu CJ; Shih JY
    Clin Lung Cancer; 2019 Nov; 20(6):e620-e630. PubMed ID: 31327643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Advantage of Targeted Next-Generation Sequencing over qPCR in Testing for Druggable
    Szpechcinski A; Moes-Sosnowska J; Skronska P; Lechowicz U; Pelc M; Szolkowska M; Rudzinski P; Wojda E; Maszkowska-Kopij K; Langfort R; Orlowski T; Sliwinski P; Polaczek M; Chorostowska-Wynimko J
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions.
    Oxnard GR; Lo PC; Nishino M; Dahlberg SE; Lindeman NI; Butaney M; Jackman DM; Johnson BE; Jänne PA
    J Thorac Oncol; 2013 Feb; 8(2):179-84. PubMed ID: 23328547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The state of the art of EGFR exon 20 insertions in non-small cell lung cancer: Diagnosis and future perspectives.
    Dorta-Suárez M; de Miguel M; Amor-Carro O; Calderón JM; González-Ortega M; Rodríguez-Abreu D
    Cancer Treat Rev; 2024 Mar; 124():102671. PubMed ID: 38281403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel drugs targeting EGFR and HER2 exon 20 mutations in metastatic NSCLC.
    Baraibar I; Mezquita L; Gil-Bazo I; Planchard D
    Crit Rev Oncol Hematol; 2020 Apr; 148():102906. PubMed ID: 32109716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous Responses to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) in Patients with Uncommon EGFR Mutations: New Insights and Future Perspectives in this Complex Clinical Scenario.
    Russo A; Franchina T; Ricciardi G; Battaglia A; Picciotto M; Adamo V
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30901844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The research status and development trend of EGFR gene exon 20 insertion mutant non-small cell lung cancer].
    Yang GJ; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2020 Jan; 42(1):22-29. PubMed ID: 32023765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors.
    Chang LC; Lim CK; Chang LY; Chen KY; Shih JY; Yu CJ
    Eur J Cancer; 2019 Sep; 119():77-86. PubMed ID: 31425965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis.
    Van Sanden S; Murton M; Bobrowska A; Rahhali N; Sermon J; Rodrigues B; Goff-Leggett D; Chouaid C; Sebastian M; Greystoke A
    Target Oncol; 2022 Mar; 17(2):153-166. PubMed ID: 35226283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of EGFR kinase domain duplication to targeted therapies in NSCLC.
    Wang J; Li X; Xue X; Ou Q; Wu X; Liang Y; Wang X; You M; Shao YW; Zhang Z; Zhang S
    Int J Cancer; 2019 Jun; 144(11):2677-2682. PubMed ID: 30255937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Frequency of Epidermal Growth Factor Receptor (EGFR) mutations in Iraqi patients with Non-Small Cell Lung Cancer (NSCLC).
    Ramadhan HH; Taaban DF; Hassan JK
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):591-596. PubMed ID: 33639678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies and Progress of EGFR exon 20 Insertion Mutation in Non-small Cell Lung Cancer].
    Zhou W; Zhang W; Han B
    Zhongguo Fei Ai Za Zhi; 2020 Feb; 23(2):118-126. PubMed ID: 32093456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and Detectability of EGFR Exon 20 Insertion Variants in NSCLC.
    Ou SI; Hong JL; Christopoulos P; Lin HM; Vincent S; Churchill EN; Soeda J; Kazdal D; Stenzinger A; Thomas M
    J Thorac Oncol; 2023 Jun; 18(6):744-754. PubMed ID: 36738930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of
    Skrickova J; Pesek M; Opalka P; Koubkova L; Zemanova M; Hrnciarik M; Blazek J; Svaton M; Krejci J; Coupkova H; Dolezal D; Tuzova T; Holubec L; Mahadevia P; Sandstrom K; Kunovszki P; Barinova M; Hurdalkova K; Fischer O; Cernovska M; Bratova M
    Anticancer Res; 2021 Nov; 41(11):5625-5634. PubMed ID: 34732435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations.
    Passaro A; Prelaj A; Bonanno L; Tiseo M; Tuzi A; Proto C; Chiari R; Rocco D; Genova C; Sini C; Cortinovis D; Pilotto S; Landi L; Bennati C; Camerini A; Toschi L; Putzu C; Cerea G; Spitaleri G; Cappuzzo F; de Marinis F
    Clin Lung Cancer; 2019 Mar; 20(2):e186-e194. PubMed ID: 30563752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas.
    Sharma S; Satapathy A; Aggarwal A; Dewan A; Jain E; Katara R; Kumar V; Pal R; Pandey S; Naidu MM; Kini L; Pradhan D; Mohanty SK
    Pathol Res Pract; 2021 Apr; 220():153394. PubMed ID: 33706124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.
    Kim HJ; Lee KY; Kim YC; Kim KS; Lee SY; Jang TW; Lee MK; Shin KC; Lee GH; Lee JC; Lee JE; Kim SY
    Lung Cancer; 2012 Mar; 75(3):321-5. PubMed ID: 21930325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR exon 20 insertions in advanced non-small cell lung cancer: A new history begins.
    Remon J; Hendriks LEL; Cardona AF; Besse B
    Cancer Treat Rev; 2020 Nov; 90():102105. PubMed ID: 32979839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of epidermal growth factor receptor gene mutations in non-small cell lung cancers by real-time polymerase chain reaction using scorpion amplification refractory mutation system].
    Zhang J; Liang ZY; Zeng X; Wu SF; Gao J; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):294-9. PubMed ID: 18956645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.